Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Arab Drug Company (ADCO) is a leading Egyptian pharmaceutical manufacturer established in 1963 and headquartered in Cairo. As a key subsidiary of the state-owned Holding Company for Pharmaceuticals, Chemicals and Medical Supplies (HoldiPharma), ADCO plays a vital role in the regional healthcare sector by producing a diverse range of affordable generic medicines. The company's extensive product portfolio spans multiple therapeutic areas, including anti-infectives, gastroenterology, cardiology, and respiratory health, available in various dosage forms such as oral solids, liquids, and topicals. ADCO is publicly traded on the Egyptian Exchange and is recognized for its commitment to international quality standards, exporting its products to numerous countries across the Middle East and Africa. The company continues to modernize its manufacturing facilities to meet growing regional demand for essential human and veterinary medicines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Arab Company for Pharmaceuticals.